Publications:148
- Home
- Profiles
M. Cecilia Berin, PhD
- About Me
- Education & Certifications
- Publications
- Industry Relationships
About Me
Language
Position
About Me
Language
Position
Education
BSc(Hons), Queen's University
MSc, Queen's University
PhD, McMaster University
Postdoctoral, University of California, San Diego
Publications
Selected Publications
- A Phenotypically Distinct Human Th2 Cell Subpopulation Is Associated With Development of Allergic Disorders in Infancy. Catherine R. Pizzarello, Courtney M. Jackson, Katherine Herman, Antti E. Seppo, Jonathan Rebhahn, Tyler Scherzi, M. Cecilia Berin, R. John Looney, Tim R. Mosmann, Kirsi M. Järvinen. Allergy: European Journal of Allergy and Clinical Immunology
- Differential T follicular helper cell phenotypes distinguish IgE-mediated milk allergy from eosinophilic esophagitis in children. Daniel Lozano-Ojalvo, Xin Chen, Wajiha Kazmi, David Menchén-Martínez, Leticia Pérez-Rodríguez, Weslley Fernandes-Braga, Scott Tyler, Keith Benkov, Nanci Pittman, Joanne Lai, Hugh A. Sampson, Maria Curotto de Lafaille, David Dunkin, M. Cecilia Berin. Journal of Allergy and Clinical Immunology
- Current status and future directions in food protein–induced enterocolitis syndrome: An NIAID workshop report of the June 22, 2022, virtual meeting. Anna Nowak-Wegrzyn, Scott H. Sicherer, Cem Akin, Sara Anvari, Lisa M. Bartnikas, M. Cecilia Berin, Theresa A. Bingemann, Scott Boyd, Terri Brown-Whitehorn, Supinda Bunyavanich, Antonella Cianferoni, George du Toit, John E. Fortunato, Jeffrey D. Goldsmith, Marion Groetch, Stephanie A. Leonard, Meenakshi Rao, Fallon Schultz, Julie M. Schwaninger, Carina Venter, Amity Westcott-Chavez, Robert A. Wood, Alkis Togias. Journal of Allergy and Clinical Immunology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Berin has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Berin has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.